Animal Imaging &
Preclinical Testing

The Animal Imaging & Preclinical Testing Core Facility provides training and access to instrumentation for in vivo, whole animal imaging, including bioluminescence, fluorescence, ultrasound, MRI, PET/CT, and microCT technologies.

In addition the Core provides assistance with design, approval, and execution of preclinical trials to assist and accelerate the process of moving scientific breakthroughs from the bench tops of the Koch Institute to the clinics for cancer patients. Our goal is to support and encourage translational efforts using refined mouse models of human cancers to test:

• Chemotherapeutic response and drug resistance
• Biosensors for tumor detection and monitoring
• Diagnostic assays
• Cancer vaccines
• Drug delivery systems and tumor-targeted modalities

Access is available to all members of the MIT community, to the extent permitted by available capacity. Priority access is given to KI members and NCI-funded research projects in recognition of funding support.  In special circumstances, access may be available to non-MIT users (details available on request from Interim Core Leader Wei Huang).